Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems explores the development of novel therapeutics and diagnostics to improve pulmonary disease management, looking down to the nanoscale level for an efficient system of targeting and managing respiratory disease. The book examines numerous nanoparticle-based drug systems such as nanocrystals, dendrimers, polymeric micelles, protein-based, carbon nanotube, and liposomes that can offer advantages over traditional drug delivery systems. Starting with a brief introduction on different types of nanoparticles in respiratory disease conditions, the book then focuses on current trends in disease pathology that use different in vitro and in vivo models.
The comprehensive resource is designed for those new to the field and to specialized scientists and researchers involved in pulmonary research and drug development.
- Explores recent perspectives and challenges regarding the management and diagnosis of chronic respiratory diseases
- Provides insights into how advanced drug delivery systems can be effectively formulated and delivered for the management of various pulmonary diseases
- Includes the most recent information on diagnostic methods and treatment strategies using controlled drug delivery systems (including nanotechnology)
